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Radioimmunoassay of Serum Deoxycorticosterone: Normal Values and Changes of Serum Deoxy-
corticosterone after Adrenal Stimulation1)
By M Schöneshöfer, W. Oelkers and Helga Harendt
Division of Endocrinology, Department of Internal Medicine, Klinikum Steglitz, Freie Universität Berlin
(Eingegangen am 31. Oktober 1974/25. Februar 1975)
A sensitive radioimmunoassay for estimating serum deoxycorticosterone is described which involves descending "overrunning" paper
chromatography. An ethanolic paper eluate is used as a solvent for unlabelled deoxycorticosterone in the preparation of the standard
curve. The values of the water blanks (7 ng/1) are similar to the sensitivity of the standard curve (5.8 ng/1). The normal mean serum con-
centration of deoxycorticosterone was found to be 84 ± 29 ng/1 (n = 30) in males and 55 ± 31 ng/1 (n = 35) in females. Serum deoxy-
corticosterone rose in healthy subjects upon injection of ACTH, after induction of insulin hypoglycemia and after administration of
metyrapone, while the rise was absent or blunted in patients with Addison's disease and in patients with pituitary failure.
Es wird ein empfindlicher Radioimmunoassay zur Bestimmung von Desoxycorticosteron im menschlichen Serum beschrieben. Eine
weitgehende Vortrennung von Desoxycorticosteron wird durch eine absteigende „Durchlauf'-Papierchromatographie erzielt. Als
Lösungsmittel für unmarkiertes Despxycorticosteron zur Erstellung der Standardkurve wird das äthanolische Eluat aus chromatogra-
phiertem „Blank"-Papier verwendet. Wasser-„Blanks" (7 ng/1) liegen dadurch in der gleichen Größenordnung wie die Empfindlichkeit
der Standardkurve (5, 8 ng/1). Die Normalwerte von Serum-Desoxycorticosteron betragen bei Männern 84 ± 29 ng/1 (n = 30) und bei
Frauen 55 ± 31 ng/1 (n = 35). Bei Gesunden steigt die Serum-Desoxycorticosteron-Konzentration nach Injektion von ACTH und Insu-
lin, sowie nach oraler Gabe von Metopiron an, während der Anstieg bei Addison-Patienten und bei Patienten mit Hypophyseninsuffi-
zienz ausbleibt, bzw. stark abgeschwächt ist.
11-Deoxycorticosterone causes hypertension in patients
with 11-hydroxylase deficiency (1,2) and it may play
a role in the pathogenesis of "low renin hypertension"
(3—5). An adequate study of these diseases necessitates
a sensitive assay of deoxycorticosterone in man. Several
methods for estimating secretion, excretion and plasma
concentration of deoxycorticosterone have been deve-
loped in the last ten years. These methods are based
on double isotope dilution (6, 9), competitive protein
binding (7), gas liquid chromatography (8) and radio-
immunoassay technique (9—11). Mean plasma deoxy-
corticosterone concentrations in normal subjects repor-
ted hitherto in the literature exhibit a considerable
variability (range: 50-260 ng/1) which is obviously due
to limited specificity and various blank problems. We
describe in this paper a sensitive radioimmunoassay of
serum deoxycorticosterone concentration involving
"overrunning" paper chromatography, and in which
blank paper eluate serves as a solvent for unlabelled
standard deoxycorticosterone. Normal values in males
and females and changes of serum deoxycorticosterone
levels after adrenal stimulation are reported.
*) Supported by Deutsche Forschungsgemeinschaft
Materials and Methods
Solvents and reagents
Analytical grade chemicals were used throughout. Deoxycorti-
costerone (21-hydroxy-4-pregnene-3.20-dione) was obtained
from E. Merck (Darmstadt). Dilutions of deoxycorticosterone
for the radioimmunoassay standard curve were set up monthly.
[1.2-3H]-deoxycorticosterone (50 Ci/mmole) was purchased
from New England Nuclear Company and purified by paper
chromatography fortnightly.
The anti^serum from rabbits immunized by injection of deoxy-
corticosterone-3-carboxy-methoxime was kindly provided by
Dr. R. Fräser, MRC Blood Pressure Unit, Glasgow.
Borate buffer (pH 8) containing 2% ethanol and 0.1% lysozyme
(E. Merck, Darmstadt) was used for incubation.
Tritium was measured in a liquid-scintillation spectrometer
(Packard Instruments, model 3385).
Pipettes and counting vials were of the disposable type. Conical
extraction tubes were washed with dilute detergent for several
hours and thoroughly rinsed with distilled water followed by
three washings with dichloromethane. Immediately before use
they were rewashed twice with dichloromethane. Whatman-2-
paper strips (1.8 X 45 cm) to be used for chromatography were
extracted with ethanol for 24 hours in a Soxleth apparatus.
Immediately before use, the strips were extracted chromato-
graphically with ethanol for about 4 hours.
Extraction and chromatography
Serum samples (0.5-3 ml) to which 3H-deoxycorticosterone
(0.018 /tiCi) had been added, were extracted with 9 ml carbon
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tetrachloride in conical glass tubes. The extracts were eva-
porated to dryness under a stream of nitrogen at 40 °C. The
residues were redissolved in 150 μΐ of dichloromethane and
chromatographed in the system n-hexane/methanol/water
(10 + 8 + 2 by vol). After 20 hours, deoxycorticosterone had
moved about 12 cm. 3H-deoxycorticosterone was located on
paper strips by radio-scanning (Packard Instruments, model
7200). 3H-deoxycorticosterone was eluted from the paper
with 2 ml of ethanol.
Radioimmunoassay
From these eluates, duplicate aliquots of 500 μΐ were pipetted
into 1.6 ml plastic tubes for radioimmunoassay, and a further
500 μΐ aliquot was pipetted into a counting vial for estimating
3H-recovery. Where necessary, the counts in the radioimmuno-
assay aliquots were adjusted to standard curve 3H-level by
adding appropriate 3H-deoxycorticosterone quantities.
Standard curves were set up in duplicate. Unlabelled deoxycorti-
costerone (800 pg to 6.24 pg in doubling dilution steps) was
dissolved in 500 μΐ of an ethanolic paper blank eluate. 0.003 μΟ
of 3H-deoxycorticosterone in 100 μΐ ethanol was added for each
standard tube.
Both unknown and standard curve samples were evaporated
to dryness under a stream of nitrogen at 40 °C 0.5 ml of anti-
serum, diluted 1:12 000 with borate-lysozyme-buffer, was
added and mixed for 30 min on a rotatory mixer at room tempe-
rature. After incubation at 4 °C for 16 hours, separation of
free and bound deoxycorticosterone was achieved using the
dextran-coated charcoal method (12). After centrifugation, the
supernatant was transferred into counting vials using a semi-
automatic decanting apparatus (according to P. Vecsei, Heidel-
berg) which allows simultaneous decanting of 150 tubes. The
percentage of activity in the supernatant represents the hormone
fraction bound to the antibody.
Evaluation of the radioimmunoassay data and plotting of stan-
dard curves were done with a modular constructed computer
program (13). An IBM-1800 computer was used for the
operating procedures. Results presented in this paper were
obtained by evaluation according to a logarithmic interpolation
model.
Results
Physicochemical constants of the 3H-deoxycorti-
costerone-antibody reaction
The equilibrium constant for the deoxycorticosterone-
antibody reaction determined by Scatchard plot is
3 · 109 1/mol at 4 °C. The rate of dissociation of the
3H-labelled deoxycorticosterone-antibody complex at
4 °C was determined by preincubation for two hours
at 4 °C followed by the addition of 2000 pg of un-
labelled deoxycorticosterone; 3H-measurement of the
supernatant in 1 hour steps up to 7 hours then permitted
the estimation of the dissociation rate of bound 3H-
deoxycorticosterone. The semilogarithmic plot of the .
results yielded a straight line indicating a first order
reaction. Half-life time of dissociation was 3.8 hours.
The dissociation constant was calculated to be 5 · 10"5
s"1 and the association constant 1,5 · 10s 1/mol · s.
Standard curve parameters
Figure 1 shows a semilogarithmic computer plot of a
representative standard curve including the 95% confi-
dence range (13). The mean sensitivity of standard
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Fig. 1. A representative semilogarithmic standard curve of
deoxycorticosterone fadioimmunoassay. Broken lines
indicate the 95% conildencel range (13).
curves (2 standard deviations of the zero point) was
3.5 ± 2.8 (S.D.) pg of deoxycorticosterone. This corre-
sponds to 5.8 ± 4.64 (S.D.) ng/1 for the deoxycorti-
costerone assay when 3 ml of serum were used.
As further measure of sensitivity of the standard curve *
we determined the amount of nlabelled deoxycorti-
costerone which displaced 50% of the labelled hormone
from the antibody. The mean sensitivity calculated from
34 standard curves was 71 ± 12 (S.D.) pg corresponding to
118 ± 19.9 (S.D.) ng/1 for a 3 ml serum sample.
Assay parameters
The ultimate specificity of the assay was achieved by
the applied "overrunning" Chromatographie system
which provides a high degree of separation of deoxycor-
ticosterone from the other major C2rSteroids. Mono-
hydroxylated progesterone derivates exhibit a Chromato-
graphie behaviour similar to that of deoxycorticosterone
but only 17 α-hydroxy-progesterone (RDoc ~ 0-68)
arises in appreciable amounts in human serum (16).
The cross reaction of 17 α-hydroxy-progesterone with
the deoxycorticosterone-antibody was found to be less
than 0.01%. /
Recovery of 3H-labelled deoxycorticosterone added to
serum averaged 53.5±6.1%(n = 35) after chromato-
graphy.
Distilled water was used for blank studies. The mean
value of 3 ml water blanks which were run in 21 diffe-
rent assays was 7 ± 11.3 ng/1. It must be stressed that
sometimes slightly negative values were obtained. Such
values were necessarily considered as zeros in the cal-
culation of mean. Therefore, the indicated mean value
of water blanks is overestimated. The mean blank of
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the Chromatographie paper determined by a standard
curve with pure ethanol as solvent for unlabelled deoxy-
corticosterone was 13.5*± 5.8 (S.D) pg/tube correspon-
ding to 22.4 ± 9.6 (S.D.) ng/1 for a 3 ml serum sample.
As a consequence of these blank studies, we used paper
eluate as the solvent for standard deoxycorticosterone
in the final method.
Accuracy of the deoxycorticosterone radioimmuno-
assay was studied by adding various amounts of unla-
belled deoxycorticosterone to distilled water or serum
with known deoxycorticosterone concentration. The
results are shown in Table 1.
Intraassay and interassay variability of deoxycorti-
costerone measurements in sera with different deoxy-
corticosterone concentrations is shown in Table 2. Both
exhibit the well-known inverse relationship between
concentration and relative error.
Different amounts of pooled serum (0.5, 1, 1.5, 2, 2.5
and 3 ml) were assayed in order to study the influence
of serum volume on assay accuracy. Samples containing
less than 3 ml were made up to 3 ml with distilled water.
The relationship between estimated deoxycorticosterone
and original serum volume is shown in Figure 2. The
coefficient of correlation (r = 0.993) indicates the ab-
sence of a systematic error introduced by variations in
serum volume.
Normal values
Serum deoxycorticosterone concentration was measured
in 65 healthy subjects (30 males and 35 females).
2 3
Volume of s^rum [ m l ]
Fig. 2. Correlation of serum deoxycorticosterone assayed and
original serum volume (n = 12). Equation of regression:
Υ = 3.73 + 110.5 X; coefficient of correlation = 0.993.
Venous blood was taken between 8 a.m. and 2 p.m..
Mean deoxycorticosterone concentration in males and
females was 84 ± 29 (S.D.) ng/1 (range 34-142 ng/1) and
55 ±31 (S.D.) ng/1 (range 18-121 ng/1) respectively. The
difference between mean male and female serum deoxy-
corticosterone levels was statistically significant (p <
0.001 using t-test and ρ < 0.002 using Wilcoxon-tesi).
It must be pointed out that no attention was drawn to
possible changes of deoxycorticosterone levels during
the menstrual cycle in women, or to circadian variability.
Tab. 1. Accuracy of deoxycorticosterone assay in 3 ml water or
serum. Mean values derived from Ν different assays.
Deoxycortl·
costerone
added (ng/1)
66
100
264
400
528
N
18
8
17
7
17
Mean Recovered ± S.D. (%)
Water
109.5 ±
102.8 ±
105.2 ±
31.1
22.0
17.8
Serum
115.2 ±
102.2 ±
16.2
8.1
Tab. 2. Intraassay and interassay variation of serum deoxycorti-
costerone radioimmunoassay.
Intra-Assay Variation
Mean
Serum
Concen-
tration
(ng/1)
47
211
653
N
11
12
11
Coeffi-
cient
of Vari-
ation
(%)
14.2·
8.7
6.9
Inter-Assay Variation
Mean
Serum
Concen-
tration
(ng/1)
66
214
502
N
11
8
7
Coeffi-
cient
of Vari-
ation
(%)
21.7
13.4
7.8
1000-
30 60
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Fig. 3. Changes in serum deoxycorticosteronc concentration
after i.v. injection (arrow) of 250 Mg ACTH between
8 a.m. and 9 a.m., 1-3: Normal subjects; 4 and 5:
Patients with Addison's disease.
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Changes of serum deoxycorticosterone after
adrenal stimulation
Several authors have demonstrated a rise of plasma
deoxycorticosterone concentration after injection of
ACTH (6, 7^ 9). Figure 3 shows a marked increase of
serum deoxycorticosterone in 3 healthy subjects after
i.v. injection of 0.25 mg of ACTH, while no response
occurred in 2 patients with Addison's disease.
Figure 4 shows the effect of insulin induced hypogly-
cemia on serum deoxycorticosterone. It increased
markedly in 3 healthy subjects, but failed to rise in 2
patients with pituitary insufficiency. 8 hours after
administration of metyrapone (30 mg/kg body weight
800
r 400
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t [min]
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Fig. 4. Changes in serum deoxycorticosterone concentration
after i.v. injection (arrow) of 0.1 IE/kg body weight of
insulin between 8 a.m. and 9 a.m. 1-3: Normal subjects;
4 and 5: Acromegalic patients after radiotherapy.
no·
10'
10 8a.m. 4p.m. 12p.m. 8o.m.
Fig. 5. Serum deoxycorticosterone concentration before (8 a.m.)
and 8 hours after oral administration of 30 mg/kg of
metyrapone (arrow). 1-3: Healthy subjects; 4 and 5:
Acromegalic patients after radiotherapy.
at midnight) a very large increment of serum deoxycorti-
costerone was observed in 3 healthy subjects, while the
response to metyrapone in 2 patients with pituitary
insufficiency was blunted (Fig. 5).
Discussion
Estimation of the very small quantities of deoxycorti-
costerone present in serum relative to other structurally
related C-21 corticosteroids presents a considerable
analytical challenge. Up to date there is no question .
that radioimmunoassay is the most convenient technique
to solve this problem adequately. However, in spite of
the generally good specificity of antibodies raised
against deoxycorticosterone, preliminary chromato-
graphical purification is necessary before the radio-
immunoassay procedure (9—11). From the more
intensively studied radioimmunoassays of plasma aldo-
sterone (14) it is known that the Chromatographie step
is prone to produce considerable blank values which
limit the sensitivity of the assay in practice. In the
present method the mean paper blank of 13.5 pg
(corresponding to 22.5 ng/1) is eliminated by setting up
the standard curve in ethanolic eluates of chromato-
graphed paper blanks. Thereby, the blanks arising from
distilled water samples (7 ng/1) approach the theoretical
sensitivity of the standard curve (5,8 ng/1) indicating
that blanks are almost quantitatively eliminated.
The normal values measured by the present method are
within the lower range of values determined by other
authors (Tab. 3). However, the significant difference
of mean female (55 ng/1) and male (84 ng/1) deoxycorti-
costerone serum concentration has not yet been repor-
ted. Similar sex differences in the concentration of
another monohydroxylated progesterone derivate
— 17 OH-progesterone — were recently described by
Youssefnefadian et al. (16). Although partially formed
Tab. 3. Comparison of mean plasma or serum deoxycorticosterone
in normal subjects determined by different methods and
authors.
P = plasma; S = serum. DID: Double isotope dilution;
GLC: Gas-liquid chromatography; CPBA: Competitive
protein binding assay; RIA: radioimmunoassay;
SR/C1: Calculated from secretion rate and metabolic
clearance rate.
Reference
Arnold (9)
Arnold (9)
Wilson (8)
Brown (7)
Schambelan
(15)
Castro (11)
Mantero (5)
present method
Method
DID
RIA
GLC
CPBA
SR/C1
GLC
RIA
RIA
RIA
N
24
10
20
24
3
24
359
30d
Mean
(ng/1)
70 (P)
50 (P)
98 (P)
50 (P)
260 (P)
64 (P)
139 (P)
55 (S)
84
Range
(ng/1)
40-180
10-120
41^-172
50-100
28-170
18-121
34-141
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in the ovaries, the mean plasma concentration in females
during the follicular phase (400 = 150 ng/1) was signi-
ficantly lower than in males (1230 ± 650 ng/1). Only in
the luteal phase did the mean plasma concentrations in
females (1340 ± 570 ng/1) reach the normal level in
males. However, plasma corticosterone levels were found
to be higher in females (6550 ± 2710 ng/1) than in males
(3960 ± 2280 ng/1) (17). In the latter study the higher
values in females were explained by a larger response to
endogenous ACTH compared with males. Our results
are not consistent with these findings. At present, these
discrepancies cannot be explained and further studies
on possible cyclic changes of serum deoxycorticosterone
in females and of episodic deoxycorticosterone secre-
tion in both sexes, are needed.
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